MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$58,575K
Interest income
$9,459K
Other expense, net
-$64K
Interest expense
$5,797K
Loss from operations
-$59,609K
Product revenue, net
$321,083K
Total operating
expenses
$380,692K
Selling, general and
administrative
$239,976K
Research and development
$116,268K
Cost of sales
$24,448K
Back
Back
Income Statement
source: myfinsight.com
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)